leisure time -WSS

leisure time

author：comprehensive 2025-10-02 22:26:48 - browse：5271

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Verily hires former Apple Health leader as chief scientific officer

WSS

Decaf coffee targeted by food safety group under obscure FDA rule

Primary care physicians play key roles in Alzheimer's management

FDA's naming rule on biosimilars has undermined competition

Oprah kicked off a national conversation on obesity. Let's have it

Influencer to be charged after chaos erupts in New York City's Union Square

2 US Navy sailors arrested for allegedly spying for China

explore

leisure time

Wikipedia

Virginia high school admissions case could be legal follow

Why the world’s most expensive drug might be worth the price

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

White House drug shortage group privately met with industry

23andMe had bad news about my health. I wish a person had delivered it

ProMED, early warning system on disease outbreaks, in peril

After affirmative action ruling, medical educators look to 'holistic review'

For BCIs, commercial hurdles may be bigger than scientific ones

Walensky prepares to leave CDC — and Congress — behind

'Ancient DNA,' 23andMe reveal African American ancestries

leisure time

ER docs worry over extreme heat as a 'mass casualty event'

Oprah kicked off a national conversation on obesity. Let's have it

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

A cyberattack has disrupted hospitals and health care in several states

Vertex Pharmaceuticals may move headquarters in Boston

Influencer to be charged after chaos erupts in New York City's Union Square

focus

focus

focus

knowledge